| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,588 |
Annual Report to shareholders
|
26 Aug 2026 9:02AM |
$11.100 |
$9.440 |
fallen by
14.95%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$385 |
Appendix 4G and Corporate Governance Statement
|
26 Aug 2026 9:02AM |
$1.460 |
$1.805 |
risen by
23.63%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$385 |
Appendix 4E, Audited Financial Statements and Annual Report
|
26 Aug 2026 9:01AM |
$1.460 |
$1.805 |
risen by
23.63%
|
|
| Commonwealth Bank of Australia (CBA) ORDINARY FULLY PAID |
Financials |
$249,831 |
Agreement reached to settle class action
|
26 Aug 2026 9:01AM |
$157.010 |
$149.290 |
fallen by
4.92%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,588 |
ASX presentation - Full year results 2026
|
26 Aug 2026 9:00AM |
$11.100 |
$9.440 |
fallen by
14.95%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aggregated revenue slightly down to $12,023 million from $12,050 million.
- Underlying EBITA decreased by 10.8% to $734 million.
- Strong cash conversion ratio at 93.6%.
- Final dividend maintained at 25 cents per share.
- Focus on energy transition and AI-enabled project delivery.
- Diversification across sectors and regions for resilience.
- Impact from Middle East disruptions and foreign exchange translation.
- Continued investment in future growth markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$28 |
Half Year Report and Accounts
|
26 Aug 2026 9:00AM |
$0.300 |
$0.305 |
risen by
1.67%
|
|
FAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit of US$1,442,226 for the half-year ended 30 June 2026.
- Rights to a Consideration Receivable from Woodside Energy up to US$55 million.
- Capital return of approximately A$32.3 million to shareholders.
- No dividends paid, recommended, or declared during this period.
- Significant executive changes including the appointment of a new CFO and Company Secretary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,588 |
ASX release - Full year results 2026
|
26 Aug 2026 8:59AM |
$11.100 |
$9.440 |
fallen by
14.95%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Full-year results for FY26 with statutory net profit of $306 million.
- Aggregated revenue stable at $12,023 million.
- Underlying EBITA of $734 million, down 10.8% on previous corresponding period.
- Middle East conflict and currency translation impacted earnings.
- Cost-out initiatives of $132 million exceeded initial target.
- Strong bookings of $15.5 billion, up 23% from FY25.
- Backlog of $13.8 billion, up 9% from 30 June 2025.
- Unfranked final dividend of 25 cents per share declared.
- Completed $500 million share buyback, with $300 million more planned.
- Anticipates mid to high single-digit growth in revenue and EBITA for FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$24 |
RAD Doses First Patient in Second Cohort of BetaBart (RV-01)
|
26 Aug 2026 8:59AM |
$0.011 |
$0.005 |
fallen by
52.38%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics doses the first patient in the second cohort of BetaBart (RV-01) clinical trial.
- The trial is a Phase 1/2a study focused on B7-H3 expressing solid tumors.
- RV-01 is a 177Lutetium-conjugated therapeutic targeting B7-H3, a molecule overexpressed in various tumor types.
- The clinical trial aims to evaluate the safety, biodistribution, and anti-tumor activity of RV-01.
- The trial is conducted at clinical centers across the U.S.
- Phase 1/2a study will determine the recommended dose for future studies.
- Radiopharm Theranostics is a clinical-stage biopharmaceutical company focused on oncology radiopharmaceuticals.
- The study aims to enroll 61 participants with a history of various confirmed cancers.
- The 70 mCi dose level was recommended by the Safety and Monitoring Committee.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green & Gold Minerals Limited (GG1) ORDINARY FULLY PAID |
Materials |
$6 |
Outstanding Copper-Silver-Tin at Elizabeth Bluffs
|
26 Aug 2026 8:59AM |
$0.145 |
$0.090 |
fallen by
37.93%
|
|
GG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade copper-silver-tin potential identified at Elizabeth Bluffs.
- Historic and recent sampling confirm copper, silver, and tin presence.
- Past assays show high grades of copper and gold.
- GG1's rock chip sampling verifies significant mineral concentrations.
- Planned 3000m drilling campaign at Mt Wandoo to start in September 2026.
- Elizabeth Bluffs contains a 4km long mineralised chert zone.
- Historic mining focused on tin with significant copper-silver results.
- Underground sampling reveals significant copper and tin widths.
- Exploration model involves intrusion-related metal systems.
- Planned further geological mapping and drilling to define targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,588 |
Dividend/Distribution - WOR
|
26 Aug 2026 8:59AM |
$11.100 |
$9.440 |
fallen by
14.95%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,588 |
Appendix 4E 2026
|
26 Aug 2026 8:59AM |
$11.100 |
$9.440 |
fallen by
14.95%
|
|
WOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory revenue and other income decreased by 5% to $10,714 million.
- EBITA decreased by 25% to $614 million.
- NPATA decreased by 36% to $306 million.
- Total dividend of 50.0 cents per share declared.
- Costs related to transformation and restructuring excluded from underlying results.
- Appendix 4E derived from audited annual report by PWC.
- Emphasis on understanding underlying profit by excluding significant items and amortization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$11,310 |
WiseTech Global FY26 results investor presentation
|
26 Aug 2026 8:58AM |
$45.470 |
$33.630 |
fallen by
26.04%
|
|
WTC - Price-sensitive ASX Announcement
Full Release
Key Points
- FY26 revenue increased by 79% to AUD 1,395.9 million.
- Underlying EBITDA rose by 56% to AUD 644.5 million.
- AI-driven transformation contributed to AUD 34 million in annualized run-rate savings.
- 95% of total revenue was from recurring sources.
- CargoWise revenue grew by 11% to AUD 756.9 million.
- Net leverage ratio was at 2.7x with plans for further reduction.
- Strategic focus on AI efficiency and productivity gains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$121 |
NTA at 21.08.26 Pre-tax 125.10 Post-tax 121.99
|
26 Aug 2026 8:58AM |
$1.105 |
$1.135 |
risen by
2.71%
|
|
| BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$33 |
BCAL Takes Interest in Genetic Signatures to 18.46%
|
26 Aug 2026 8:57AM |
$0.052 |
$0.090 |
risen by
73.08%
|
|
BDX - Price-sensitive ASX Announcement
Full Release
Key Points
- BCAL increased its stake in Genetic Signatures Ltd to 18.46%.
- Acquisition involved 18.75 million shares for $1.5 million.
- Investment is to enhance BCAL's diagnostic platform and growth.
- BCAL focuses on early cancer detection and is based in Sydney.
- BCAL is listed on the Australian Securities Exchange as BDX.
- Genetic Signatures specializes in molecular diagnostics with 3base® technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SSH Group Ltd (SSH) ORDINARY FULLY PAID |
Industrials |
$14 |
SSH Preferred Mining Contractor for Crawford Gold Project
|
26 Aug 2026 8:57AM |
$0.140 |
$0.125 |
fallen by
10.71%
|
|
SSH - Price-sensitive ASX Announcement
Full Release
Key Points
- SSH Group Ltd selected as preferred mining services contractor for Crawford Gold Project.
- SSH to provide mining services for Stage 1 oxide pit at Crawford, located 20km east of Leonora, Western Australia.
- Commercial terms to be finalized between SSH and Cavalier Resources Limited.
- Contract expected to span 12 months of active mining operations.
- SSH aims to grow its mining services in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$11,310 |
WTC record revenue, up 79%, exceeds guidance EBITDA, up 54%
|
26 Aug 2026 8:57AM |
$45.470 |
$33.630 |
fallen by
26.04%
|
|
WTC - Price-sensitive ASX Announcement
Full Release
Key Points
- WiseTech Global's revenue increased by 79% in FY26, reaching $1,395.9 million, driven by the acquisition of e2open.
- The company's EBITDA was $558.4 million, up 46% from FY25, with an EBITDA margin of 40%.
- Underlying EBITDA was $644.5 million, up 56% with a margin of 46%.
- WiseTech achieved $115 million in annualized run-rate cost savings through various efficiency programs.
- Over 95% of CargoWise customers have transitioned to the new CargoWise Value Packs model.
- The company achieved a record Underlying Rule of 40 of 114%, significantly up from 52% in FY25.
- WiseTech's operating cash flow was $564 million, up 29%, with free cash flow of $410.7 million, up 43%.
- The company continues to integrate and standardize e2open, achieving better-than-expected EBITDA margin improvements.
- WiseTech's strategic initiatives include AI adoption and expanding product offerings with acquisitions like FRDM.ai.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$75 |
Prescient Therapeutics Opens SPP to Raise $7m Today
|
26 Aug 2026 8:57AM |
$0.067 |
$0.066 |
fallen by
1.49%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics opens a Share Purchase Plan to raise $7 million.
- Funds are aimed at advancing the cancer treatment PTX-100.
- SPP offers shares at a 9.7% discount to the closing price.
- Eligible shareholders can purchase up to $30,000 in shares.
- Proceeds will support clinical trials and regulatory approvals.
- The SPP is available to shareholders in Australia and New Zealand.
- Funds will also support business development and potential new opportunities.
- The SPP runs until 8 September 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hiremii Limited (HMI) ORDINARY FULLY PAID |
Industrials |
$6 |
Appendix 4E and Annual Report FY26
|
26 Aug 2026 8:56AM |
$0.039 |
$0.027 |
fallen by
30.77%
|
|
HMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Hiremii Limited reported a loss after income tax of $587,540 for the year ended 30 June 2026.
- Total comprehensive loss for the year attributable to owners was $587,540.
- The company issued shares in relation to business combinations amounting to $205,766.
- Shares were issued to directors in lieu of fees valued at $72,142.
- Contract assets increased to $329,999 from $227,369 in the previous year.
- Trade and other receivables as of 30 June 2026 were $2,975,924.
- Current liabilities, including trade and other payables, amounted to $3,807,956.
- Total equity at 30 June 2026 was $2,306,726.
- The weighted average number of ordinary shares used in calculating earnings per share was 180,620,705.
- The company has no contingent liabilities as of 30 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$94 |
Preliminary Final Report
|
26 Aug 2026 8:55AM |
$0.260 |
$0.405 |
risen by
55.77%
|
|
| Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$1,568 |
FY2026 AGM Presentation
|
26 Aug 2026 8:55AM |
$3.570 |
$2.800 |
fallen by
21.57%
|
|
| Ora Banda Mining Ltd (OBM) ORDINARY FULLY PAID |
Materials |
$2,826 |
Appendix 4E
|
26 Aug 2026 8:55AM |
$1.585 |
$1.460 |
fallen by
7.89%
|
|
OBM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 99.7% to $807,499,000.
- Net profit after tax increased by 16.2% to $216,195,000.
- No dividends were paid or proposed for the year.
- Net tangible assets per share increased from $0.15 to $0.28.
- No changes in controlled entities occurred.
- Joint venture interests remained stable.
- Financial statements audited by KPMG.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$173 |
FY26 Sustainability Report
|
26 Aug 2026 8:54AM |
$0.265 |
$0.225 |
fallen by
15.09%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$11,310 |
Dividend/Distribution - WTC
|
26 Aug 2026 8:54AM |
$45.470 |
$33.630 |
fallen by
26.04%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$11,310 |
WTC FY26 Appendix 4E and financial report
|
26 Aug 2026 8:54AM |
$45.470 |
$33.630 |
fallen by
26.04%
|
|
WTC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 79% to USD 1,395.9 million.
- Net profit after tax decreased by 11% to USD 178.7 million.
- Acquisition of e2open contributed significantly to revenue growth.
- Over USD 1.1 billion invested in product development over five years.
- Introduction of CargoWise Value Packs (CVP).
- Advancements in AI aimed at productivity and cost reduction.
- Dividend reinvestment plan continued.
- Operating cash flow increased by 29% to USD 564 million.
- Commitment to being the operating system for global trade and logistics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,505 |
Full Year Results Briefing
|
26 Aug 2026 8:54AM |
$10.780 |
$8.560 |
fallen by
20.59%
|
|
Call 1300 880 160
Start a chat
Schedule a call
